Phase Ib/IIa randomized study of heterologous ChAdOx1-HBV/MVA-HBV therapeutic vaccination (VTP-300) as monotherapy and combined with low-dose nivolumab in virally-suppressed patients with CHB
Tak WY., Chuang W-L., Chen C-Y., Tseng K-C., Lim Y-S., Lo G-H., Heo J., Agarwal K., Bussey L., Teoh SL., Tria A., Brown A., Anderson K., Vardeu A., O’Brien S., Kopycinski J., Kolenovska R., Barnes E., Evans T.